Navigation Links
Genta Receives NASDAQ Non-Compliance Notice
Date:12/24/2007

BERKELEY HEIGHTS, N.J., Dec. 24 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced today that the Company has been notified by the Listing Qualifications Staff of The NASDAQ Stock Market that it no longer complies with NASDAQ Marketplace Rule 4450(a)(5), which requires a minimum closing bid price of $1.00 per share. In accordance with Marketplace Rule 4450(e)(2), the Company has until June 16, 2008 to regain compliance, which requires a closing bid price of the Company's common stock at or above $1.00 per share for a minimum of 10 consecutive business days. In the event the Company does not regain compliance within this period, the Company may appeal a delisting determination by the Staff to the NASDAQ Listing Qualifications Panel, and the Company's securities would remain listed pending the Panel's decision.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Genta Announces Presentation of New Clinical and Preclinical Data on Genasense(R) at AACR-NCI-EORTC Targets Conference
2. Syngenta Licenses Chromatin Gene Stacking Technology
3. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
4. Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market
5. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
6. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
9. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
10. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
11. IsoTis Receives FDA Clearance for Accell Family of Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/8/2008)... Symphony Management Cons... as Solutions Director. , ...ymphony-consulting.com [Symphony Management Consu... as Solutions Director., , , , ,Mr. Whalen joins ... where he was responsible for designing, developin...
(Date:9/6/2008)... A free paper helps visit...s such as finding multilingual help, electronica i...es of pre-show information useful in planning a tr...us areas, conferences and events. It includes an e...and show resources. , Mun...
(Date:9/5/2008)..., Researchers from the National Institute of...l University (SNU) have learned how to tweak a new...ontrol the location and alignment of the component...e top to the bottomcould enable the design of prac...wide range of printable, flexible electronic displ...
(Date:9/5/2008)... WASHINGTON The Food & Drug Administration (FDA)... Report. This report acknowledged that nanoscale m... types regulated by the agency and that those mate...hat properties relevant to product safety and effe...oscale. , Anticipating the potential for rapid ...
Breaking Biology Technology:Symphony Managemnt Consulting Hires New Solutions Director 2Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 2Free White Paper Now Available: How to get the most from your visit to electronica 2008 in Munich 3Bottoms up: Better organic semiconductors for printable electronics 2Nanotechnology and the FDA: size matters 2
... , The chemistry, spectroscopy, and reacti...e interest in environmental applications, novel or...n. 1 Recently, research has been directed towards...such as the photodynamic destruction of cells in t...understanding of the mechanisms that produce 1 O ...
..., Protein-containing plants are staples i...ce enough crops is essential to the well-being of ...t before they can advance to higher endeavors. ,... as the amount of rainfall, the occurrence of fros...uccess of a harvest. The stress in plants induced ...
..., One of the fastest-growing segments of the...neration of graphic displays for communications an...hat might be used as the active medium in such dis...mes and wavelengths of their emissions. , ... the lifetimes and wavelengths of emissions were r...
... Kinetic fluorescence as an analytical technique... and the technique is applied to the determination...nce intensity is monitored as thiamine converts to...ablished between the rate of increase of intensity...is shown to have good sensitivity and selectivity....
Other Biology Technology:Singlet Oxygen measurement 2Food science: increasing crop yields 2Kinetic determination of vitamin B1 2Kinetic determination of vitamin B1 3Kinetic determination of vitamin B1 4
(Date:9/5/2008)...t INCF Congress of Neuroinformatics will convene S...er in Stockholm. The emerging neuroinformatics fie...to develop advanced tools and approaches to unders...he tools may also be applied to brain disorders an...he meeting will bring together experts from all di...
(Date:9/5/2008)...pulations of wild animals face the challenge of su...rial College London and Universit Claude Bernard L...island off the west coast of Scotland responds to ...vailability and the unpredictability of winter sto...evealed, "When times are good and food is plentifu...
(Date:9/5/2008)...e development and path of Hurricane Gustav is show...nvisat,s Medium Resolution Imaging Spectrometer (M...t and 1 September 2008 (from right to left). , G...st of Port-au-Prince, Haiti (seen above far right ...s and an upper level eye feature (visible), causin...
(Date:9/4/2008)...PHIA Scientists at the M.D. Anderson Cancer Cente...lung cancer specifically for African Americans tha... pulmonary disease (COPD), according to a report p...ion Research, a journal of the American Associati...analyzed data from 491 African Americans with lung...
Breaking Biology News(10 mins):INCF organizes the first congress dedicated to the emerging field of neuroinformatics 2Hurricane Gustav 2African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease 2Slow exercise 28not fast 29 is better for menopausal women 23305 1Slow exercise 28not fast 29 is better for menopausal women 23305 2Study shows rise in Cornwalls dolphin whale and porpoise deaths 3903 1Study shows rise in Cornwalls dolphin whale and porpoise deaths 3903 2Food Allergens Show Up in Unexpected Places 23301 1Food Allergens Show Up in Unexpected Places 23301 2Treatment delays result in poor outcomes for men with breast cancer 3900 1Treatment delays result in poor outcomes for men with breast cancer 3900 2
...he flowers they pollinate, has declined significan...5 years according to research led by the Universit...1 July 2006). The paper is the first evidence of a...have been raised for years about the loss of polli...idence has been restricted to a few key species or...
...er ways to target anticancer drugs to kill tumors ...nanoparticles called buckyballs might be used to s... tumor-targeting antibodies. , In research due to ...l Communications, scientists at Rice University an...nter describe a method for creating a new class of...
...stitute of Standards and Technology (NIST) have de..."boxes" for small numbers of biomolecules. The unu... experiments on single molecule dynamics and perha...ices that might be used for medical screening or b...e July 3 issue of Applied Physics Letters. , The N...
...ld soon could be made completely flood-tolerant be... done in collaboration with scientists at UC Davis...the Philippines. By gradually introducing into Cal...hat enables rice to survive extreme flood conditio...ty of rice could be made to survive short-term flo...
Other Biology News:Wild bees and the flowers they pollinate are disappearing together 2Wild bees and the flowers they pollinate are disappearing together 3Buckyballs boost antibody's chemotherapy payload 2'Micro-boxes' of water used to study single molecules 2Researchers develop flood-tolerant California rice 2Researchers develop flood-tolerant California rice 3
Mouse monoclonal [SH-A1] to S100 alpha ( Abpromise for all tested applications). entrezGeneID: 6271 SwissProtID: P23297
Novagen's Calf Liver tRNA is qualified for use in reticulocyte lysates for in vitro translation, and is the same supplement used in the Red Nova Lysate .
Recognizes rat Taste Receptor 2 (TR2). The immunogen shows no significant sequence homology with TR1, gustducin or other pheromone receptors.
Anti-Natural Killer Cell Receptor-P1, clone 1C10 Immunogen: Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized (BALB/c X C57BL/6)F1 (CbyB6F1) lymphokine-activated killer
Biology Products: